Literature DB >> 10587320

Hospital admission policy for tuberculosis in pulmonary centres in Italy: a national survey. AIPO Tuberculosis Study Group. Italian Association of Hospital Pulmonologists.

S Nutini1, F Fiorenti, L R Codecasa, L Casali, G Besozzi, G Di Pisa, S Nardini, G B Migliori.   

Abstract

SETTING: A national survey including 203 pulmonary centres (PCs) (144 hospital PCs with beds dedicated to TB patients and 59 out-patient PCs) managing tuberculosis cases in Italy during 1995.
OBJECTIVES: To evaluate: 1) hospitalisation practices (criteria for admission/discharge; duration of hospitalisation) as primary end-points; and 2) as secondary end-points the availability of beds, the preventive measures adopted to reduce the spread of infection, the sources of referral for hospitalisation and the procedures adopted to follow up TB patients after discharge.
DESIGN: A 26-point questionnaire mailed to 203 PCs.
RESULTS: Of 167 PCs that responded to the questionnaire (82.3%), 159 questionnaires were considered valid for the analysis (110 from hospitals PCs and 49 from out-patient PCs). The criteria adopted by PCs to admit TB patients were: all TB cases 47%, only smear-positive pulmonary TB 14%, TB cases with clinical problems 39%. Hospital PCs hospitalised significantly more cases of smear-negative, extra-pulmonary TB. On average 71.6% of all cases were hospitalised (88.2% by hospital and 28% by out-patient PCs). The median hospital stay was 34 days for sputum smear-positive, 20 for sputum smear-negative and 21.5 for extra-pulmonary TB cases. Sputum conversion was considered the mandatory criterion to allow discharge from 61% of hospital PCs.
CONCLUSION: A switch from the present policy (majority of cases hospitalised for a long period) to an outpatient oriented policy needs the co-ordinated educational effort of scientific societies and health authorities.

Entities:  

Mesh:

Year:  1999        PMID: 10587320

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Factors that associated with TB patient admission rate and TB inpatient service cost: a cross-sectional study in China.

Authors:  Hongyan Hu; Jiaying Chen; Kaori D Sato; Yang Zhou; Hui Jiang; Pingbo Wu; Hong Wang
Journal:  Infect Dis Poverty       Date:  2016-01-20       Impact factor: 4.520

2.  Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study.

Authors:  Lisa A Ronald; J Mark FitzGerald; Andrea Benedetti; Jean-François Boivin; Kevin Schwartzman; Gillian Bartlett-Esquilant; Dick Menzies
Journal:  BMC Infect Dis       Date:  2016-11-15       Impact factor: 3.090

3.  HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.

Authors:  Ken Tashiro; Nobuyuki Horita; Kenjiro Nagai; Misako Ikeda; Masaharu Shinkai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Atsuya Narita; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

Review 4.  Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence.

Authors:  Giovanni Battista Migliori; Dina Visca; Martin van den Boom; Simon Tiberi; Denise Rossato Silva; Rosella Centis; Lia D'Ambrosio; Tania Thomas; Emanuele Pontali; Laura Saderi; H Simon Schaaf; Giovanni Sotgiu
Journal:  Pulmonology       Date:  2021-01-28

5.  Hospitalizations and Treatment Outcomes in Patients with Urogenital Tuberculosis in Tashkent, Uzbekistan, 2016-2018.

Authors:  Bakhtiyor Ismatov; Yuliia Sereda; Serine Sahakyan; Jamshid Gadoev; Nargiza Parpieva
Journal:  Int J Environ Res Public Health       Date:  2021-04-30       Impact factor: 3.390

6.  Influence of Hospitalization upon Diagnosis on the Risk of Tuberculosis Clustering.

Authors:  Giuseppe Lapadula; Fabio Zanini; Luigi Codecasa; Fabio Franzetti; Maurizio Ferrarese; Manuela Carugati; Ester Mazzola; Consuelo Schiroli; Davide Motta; Diego Iemmi; Andrea Gori
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-20       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.